乐普生物-B:中国证监会向公司发出有关H股全流通申请的备案通知书

格隆汇资讯
May 28, 2025

格隆汇5月28日丨乐普生物-B(02157.HK)公告,公司已于近期向中国证券监督管理委员会("中国证监会")提交有关公司进行H股全流通的备案。公司已代表公司若干股东向中国证监会提出备案申请,将其持有的公司合计54,268,364股境内未上市股份转换为公司H股并在联交所上市("转换及上市")。公司欣然宣布,于2025年5月26日,中国证监会已向公司发出转换及上市备案通知书("备案通知书")。根据...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10